$CMPS up 17% today and I honestly think $40 is way more realistic than people think.
They’re already in Phase 3 for treatment-resistant depression, have FDA breakthrough therapy designation, and if COMP360 gets approved this instantly becomes one of the biggest names in psychedelic medicine.
At $40 the market cap still wouldn’t be crazy for a company leading a completely new treatment category with massive demand.
Feels like the market is finally starting to price in the possibility that this actually works.